Industry update
Canada continues to open the door for clinical research the effectiveness of psilocybin for mental health treatments
Hi, what are you looking for?
Canada continues to open the door for clinical research the effectiveness of psilocybin for mental health treatments
The Denver-based company says the new milestone will advance global research for medical psilocybin as depression rises during the pandemic
With deep Canadian and U.S. military ties, NeuroPharm Inc. is about to launch psychedelic-based clinical trials
